Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Dermatol ; 175(5): 1049-1051, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26992073

RESUMO

We present two cases of patients with systemic autoimmune diseases (one with dermatomyositis and one with CREST syndrome) who presented with a worsening of calcinosis cutis after treatment of osteoporosis with teriparatide. To our knowledge, this association is not described in the literature and might be considered in the spectrum of adverse reactions to teriparatide.


Assuntos
Conservadores da Densidade Óssea/efeitos adversos , Calcinose/induzido quimicamente , Osteoporose/tratamento farmacológico , Dermatopatias/induzido quimicamente , Teriparatida/efeitos adversos , Idoso , Síndrome CREST/complicações , Dermatomiosite/complicações , Feminino , Humanos , Pessoa de Meia-Idade , Osteoporose/complicações
2.
Int J Neurosci ; 125(12): 936-40, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25350870

RESUMO

Tumor Necrosis Factor-alpha (TNF-α) is an immunomodulatory and proinflammatory cytokine implicated in neuro-inflammation and neuronal damage in response to cerebral ischemia. The present study tested the hypothesis that anti-TNF-α agents may be protective against cerebral infarction. Transient focal ischemia was artificially induced in anesthetized adult male Wistar rats (300-350 g) by middle cerebral artery occlusion (MCAO) with an intraluminal suture. TNF-α function was interfered with either a chimeric monoclonal antibody against TNF-α (infliximab-7 mg/kg) aiming to TNF-α soluble and membrane-attached form; or a chimeric fusion protein of TNF-α receptor-2 with a fragment crystallizable (Fc) region of IgG1 (etanercept-5 mg/kg) aiming for the TNF-α soluble form. Both agents were administered intraperitoneally 0 or 6 h after inducing ischemia. Infarct volume was measured by 2,3,5-triphenyltetrazolium chloride staining. Cerebral infarct volume was significantly reduced in either etanercept or infliximab-treated group compared with non-treated MCAO rats 24 h after reperfusion. These results suggest that anti-TNF-α agents may reduce focal ischemic injury in rats.


Assuntos
Lesões Encefálicas/prevenção & controle , Etanercepte/uso terapêutico , Infliximab/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Fator de Necrose Tumoral alfa/metabolismo , Animais , Infarto Encefálico/etiologia , Infarto Encefálico/prevenção & controle , Lesões Encefálicas/etiologia , Modelos Animais de Doenças , Infarto da Artéria Cerebral Média/complicações , Infarto da Artéria Cerebral Média/tratamento farmacológico , Masculino , Ratos , Ratos Wistar , Fatores de Tempo , Fator de Necrose Tumoral alfa/imunologia
3.
Rheumatol Int ; 34(5): 723-5, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-23292188

RESUMO

We report an adult female patient with Takayasu arteritis (TA) receiving conventional medical treatment and anti-TNF therapy, which developed progressive thoracic and abdominal aortic aneurysms. She developed imminent rupture of the thoracic aneurysm and an endovascular stent-graft (EVSG) was emergency implanted and a year after this procedure the abdominal aneurysm increased in size requiring reoperation and placement of another EVSG. Both procedures had a very good outcome. This case shows the effectivity and security of multiple EVSG implantations in multiple aortic aneurisms in patients with TA.


Assuntos
Aneurisma da Aorta Abdominal/cirurgia , Aneurisma da Aorta Torácica/cirurgia , Implante de Prótese Vascular/instrumentação , Prótese Vascular , Procedimentos Endovasculares/instrumentação , Stents , Arterite de Takayasu/complicações , Arterite de Takayasu/tratamento farmacológico , Adulto , Aneurisma da Aorta Abdominal/diagnóstico , Aneurisma da Aorta Abdominal/etiologia , Aneurisma da Aorta Torácica/diagnóstico , Aneurisma da Aorta Torácica/etiologia , Aortografia/métodos , Produtos Biológicos/uso terapêutico , Feminino , Humanos , Reoperação , Arterite de Takayasu/diagnóstico , Arterite de Takayasu/imunologia , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Fator de Necrose Tumoral alfa/antagonistas & inibidores
4.
Rheumatol Int ; 32(2): 541-3, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21267573

RESUMO

Relapsing polychondritis (RP) is an autoimmune disease characterized by inflammation and destruction of all type of body cartilage, and the cartilage trauma may be a trigger of the disease in a susceptible person. We describe the clinical and laboratory findings in a group of 18 patients with RP with (7 cases) or without (11 cases) anteceding cartilage trauma. The mean age was 41 years in the group with cartilage trauma and 55 years in the group without cartilage trauma. For both groups, female gender was predominant. All patients presented with auricular chondritis. Systemic manifestations and autoimmunity were more common in patients with anteceding trauma.


Assuntos
Doenças Autoimunes/diagnóstico , Cartilagem/imunologia , Cartilagem/lesões , Policondrite Recidivante/diagnóstico , Ferimentos e Lesões/diagnóstico , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças Autoimunes/epidemiologia , Cartilagem/patologia , Comorbidade/tendências , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Policondrite Recidivante/epidemiologia , Policondrite Recidivante/imunologia , Estudos Retrospectivos , Ferimentos e Lesões/epidemiologia , Ferimentos e Lesões/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...